) was a big mover last session, as the company saw its shares rise
by nearly 10% on the day. The move came on solid volume too with
far more shares changing hands than in a normal session. This
reverses the recent trend for the company, as the stock is now down
13% in the past one-month time frame.
This medical products company has seen a mixed track record when it
comes to estimate revisions of 4 increases and 1 decrease over the
past two months, and the Zacks Consensus Estimate went down over
the same time frame. The recent price action is encouraging though,
so make sure to keep a close watch on this firm in the near future.
Unilife currently has a Zacks Rank #3 (Hold) while its
Some better performing stocks in the same industry include
Hill-Rom Holdings, Inc.
Boston Scientific Corporation
). While Hill-Rom Holdings and NuVasive hold a Zacks Rank #1
(Strong Buy), Boston Scientific carries a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research?
Today, you can download
7 Best Stocks for the Next 30 Days
Click to get this free report >>
BOSTON SCIENTIF (BSX): Free Stock Analysis
HILL-ROM HLDGS (HRC): Free Stock Analysis
NUVASIVE INC (NUVA): Free Stock Analysis Report
UNILIFE CORP (UNIS): Free Stock Analysis Report
To read this article on Zacks.com click here.